Phase IV trials, also known as post-marketing surveillance studies, are conducted after a new cancer treatment has been approved by regulatory authorities such as the FDA. These trials aim to monitor the long-term effectiveness and safety of the treatment in a broader patient population. Unlike earlier phases, which focus primarily on efficacy and safety, Phase IV trials provide additional information on optimal use, side effects, and potential rare adverse events.
